Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Parliament’s Trade Committee votes for jobs and access to medicines with a comprehensive SPC Manufacturing Waiver

4 December 2018

The Medicines for Europe Board unanimously applauds last night’s vote […]

Read more

Medicines for Europe welcomes Competitiveness Council discussion to stop delocalisation of medicine manufacturing. It is time to effectively position Europe as a global hub for the production of medicines

30 November 2018

Yesterday, 29th November, members of the Competitiveness Council expressed strong […]

Read more

Parliament’s Health Committee (ENVI) introduces constructive amendments to SPC Manufacturing waiver vote in its official opinion to the Parliament’s Legal Committee (JURI)

27 November 2018

The introduction of comprehensive SPC manufacturing waiver key to unlocking […]

Read more

Health at a Glance Report highlights public value of generic, biosimilar and value added medicines

26 November 2018

The European Commission and OECD – Health at a Glance: […]

Read more

Driving local excellence, delivering European results

5 November 2018

Medicines for Europe is glad to announce the occasion of […]

Read more

Risk that European Council will “neuter” SPC manufacturing waiver and give foreign (non-EU) manufacturers strong advantage over EU-based manufacturers

11 October 2018

There is a concrete risk that disproportionate influence on the […]

Read more

CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court

20 September 2018

An English Court has determined that the contested supplementary protection […]

Read more

SPC manufacturing waiver is good news for Europe

19 September 2018

An SPC manufacturing waiver should be extremely beneficial for Europe […]

Read more

SPC manufacturing waiver moves a step closer as influential European Parliament ENVI Committee supports reform

17 September 2018

Medicines for Europe welcomes the European Parliament’s Committee on Environment, […]

Read more

Multi-stakeholder workshop on biosimilar medicines a crucial milestone in achieving increased patient access to biological therapies

14 September 2018

Open

Subscribe to our newsletter